Diphtheria
Corynebacterium diphtheriae
stain of diphtheria
CDC describes diphtheria as "an upper respiratory tract illness characterized by sore throat, low-grade fever, and an adherent membrane of the tonsil(s), pharynx, and/or nose". Diphtheria is a rapidly developing, acute, febrile infection which involves both local and systemic pathology. A local lesion develops in the upper respiratory tract and involves necrotic injury to epithelial cells. As a result of this injury, blood plasma leaks into the area and a fibrin network forms which is interlaced with with rapidly-growing C. diphtheriae cells.
Author: Chu
DoD Instruction 6025.19
12 Oct 05

Sample Q&A: Diphtheria- The Vaccine

Who recommends this vaccine?
The Centers for Disease Control and Prevention (CDC), the American Academy of Pediatrics (AAP), and the American Academy of Family Physicians (AAFP) all recommend this vaccine.
Recommendations of the Advisory Committee on Immunization Practices (ACIP) and Recommendation of ACIP, supported by the Healthcare Infection Control Practices Advisory Committee (HICPAC), for Use of Tdap Among Health-Care Personnel
Recommendations of the Advisory Committee on Immunization Practices (ACIP)
Information Paper
Package Insert - Vaccine
Package Insert - Vaccine
Package Insert - Vaccine
Package Insert - Vaccine
Package Insert - Vaccine
Package Insert - Vaccine
Package Insert - Vaccine
GlaxoSmithKline 01 Mar 12
Boostrix
GlaxoSmithKline 14 Apr 09
Pentacel
GlaxoSmithKline 26 Jun 08
Kinrix
MMQC-11-1074 02 Feb 11
UPDATED RECOMMENDATIONS FOR USE OF TETANUS TOXOID, REDUCED DIPHTHERIA TOXOID AND ACELLULAR PERTUSSIS (TDAP) VACCINE FROM THE ADVISORY COMMITTEE ON IMMUNIZATION PRACTICES, 2010
VIS